Detalhe da pesquisa
1.
Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer.
Int J Cancer;
144(8): 2020-2032, 2019 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30318841
2.
Ginsenoside Rd Inhibits the Metastasis of Colorectal Cancer via Epidermal Growth Factor Receptor Signaling Axis.
IUBMB Life;
71(5): 601-610, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30576064
3.
Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomas.
Cell Rep;
42(12): 113470, 2023 12 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37979166
4.
Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment.
J Natl Cancer Inst;
114(1): 97-108, 2022 01 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34250544
5.
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.
Sci Adv;
8(50): eabn7983, 2022 12 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36525493
6.
Targeting Signaling Pathways in Inflammatory Breast Cancer.
Cancers (Basel);
12(9)2020 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32883032
7.
20(R)-Ginsenoside Rg3 Influences Cancer Stem Cell Properties and the Epithelial-Mesenchymal Transition in Colorectal Cancer via the SNAIL Signaling Axis.
Onco Targets Ther;
12: 10885-10895, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31849492
8.
Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells.
Cells;
7(11)2018 Nov 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30423843
9.
The anti-metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2-dependent manner.
Cancer Med;
7(11): 5621-5631, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30264477
10.
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment.
Stem Cells Int;
2018: 5416923, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29681949
11.
Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer.
Oncotarget;
7(52): 86039-86050, 2016 Dec 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27852071